Corvus Pharmaceuticals Inc buy BiotechBee
Start price
08.09.24
/
50%
€3.72
Target price
31.08.27
€5.00
Performance (%)
88.71%
End price
14.12.24
€7.02
Summary
This prediction ended on 14.12.24 with a price of €7.02. The BUY prediction by BiotechBee for Corvus Pharmaceuticals Inc saw massive gains of 88.71%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -5.622% | -5.622% | 262.934% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
According to BiotechBee what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Buy mit Kursziel 5,0
In the thread Trading Corvus Pharmaceuticals Inc
Buy beendet

